Repository logo
 

Frontal-subcortical behaviors during Alzheimer's disease in individuals with Down syndrome.

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Fonseca, Luciana Mascarenhas 
Mattar, Guilherme Prado 
Haddad, Glenda Guerra 
Gonçalves, Aline Souza 
Miguel, André de Queiroz Constantino 

Abstract

There is evidence that frontal-subcortical circuits play an important role in the initial presentation of dementia in Down syndrome (DS), including changes in behavior, a decline in working memory and executive dysfunction. We evaluated 92 individuals with DS (≥30 years of age), divided into 3 groups by diagnosis-stable cognition, prodromal dementia, and Alzheimer's disease. Each individual was evaluated with an executive protocol developed for people with intellectual disabilities and was rated for behaviors related to frontal lobe dysfunction (disinhibition, executive dysfunction, and apathy) by an informant using the Frontal Systems Behavior Scale. Informant-reported behaviors related to frontal lobe dysfunction were found to correlate negatively with executive function performance. Disinhibition and executive dysfunction were associated with the clinical stage of dementia. The odds of having Alzheimer's disease increased in parallel with increases in the domain and total Frontal Systems Behavior Scale scores (p ≤ 0.5). Disinhibition, executive dysfunction and apathy should be taken into consideration during the clinical evaluation of adults with DS, and future studies should consider the intersection of neuropathology, brain connectivity, and behavior.

Description

Keywords

Alzheimer's disease, Apathy, Dementia, Disinhibition, Down syndrome, Executive dysfunction, Adult, Alzheimer Disease, Apathy, Behavior, Dementia, Down Syndrome, Executive Function, Female, Frontal Lobe, Humans, Inhibition, Psychological, Male, Memory, Short-Term, Middle Aged

Journal Title

Neurobiol Aging

Conference Name

Journal ISSN

0197-4580
1558-1497

Volume Title

78

Publisher

Elsevier BV
Sponsorship
Alzheimer's Research UK (ARUK-PG2015-23)
Medical Research Council (G1002252)
MRC (G1002252/1)